NIKTIMVO

GrowthmAb

axatilimab-csfr

BLAINTRAVENOUSINJECTABLEPriority Review
Approved
Aug 2024
Lifecycle
Growth
Competitive Pressure
30/100

Mechanism of Action

Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors

Pharmacologic Class:

Colony Stimulating Factor-1 Receptor Blocker